Neurosense Therapeutics Ltd
NRSNW
View Detailed Chart
0.440USD
+0.090+25.61%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+25.61%
5 Days
+4.19%
1 Month
-36.23%
6 Months
+112.56%
Year to Date
0.00%
1 Year
+158.98%
View Detailed Chart
TradingKey Stock Score
No scoring data
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Ticker SymbolNRSNW
CompanyNeurosense Therapeutics Ltd
CEOMr. Alon Ben-Noon
Websitehttps://www.neurosense-tx.com/
Related Instruments
+0.68%
+1.38%
-2.48%
-1.57%
-0.75%
-0.09%
+1.34%
-1.77%
-0.67%
-3.03%
-0.85%
-0.87%
-0.50%
+0.44%
-0.19%
-1.18%
-2.84%
0.00%
+0.30%
-3.72%
